Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-04 06:07 am Sale | 13D | CHEMBIO DIAGNOSTICS, INC. CEMI | PERCEPTIVE ADVISORS LLC | 0 0% | -4,919,334 (Position Closed) | View |
| 2023-05-01 09:21 am Purchase | 13D | CHEMBIO DIAGNOSTICS, INC. CEMI | Biosynex SA | 37,059,993 100% | 37,059,993 (New Position) | View |
| 2023-04-21 5:36 pm Purchase | 13D | CHEMBIO DIAGNOSTICS, INC. CEMI | PERCEPTIVE ADVISORS LLC | 4,919,334 13.4% | 494,234 (+11.17%) | View |
| 2023-04-07 5:19 pm Purchase | 13D | CHEMBIO DIAGNOSTICS, INC. CEMI | PERCEPTIVE ADVISORS LLC | 4,425,100 12% | 4,425,100 (New Position) | View |
| 2022-02-09 3:33 pm Purchase | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | VANGUARD GROUP INC | 1,405,785 4.68% | 367,502 (+35.40%) | View |
| 2021-07-12 08:29 am Sale | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | BlackRock Inc. BLK | 199,249 1% | -1,000,345 (-83.39%) | View |
| 2021-02-16 12:24 pm Sale | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | LYTTON LAURENCE W | 0 0% | -1,010,718 (Position Closed) | View |
| 2021-02-12 06:42 am Sale | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | Nantahala Capital Management LLC | 0 0% | -1,239,983 (Position Closed) | View |
| 2021-02-10 10:46 am Purchase | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | VANGUARD GROUP INC | 1,038,283 5.15% | 1,038,283 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | BlackRock Inc. BLK | 1,199,594 5.9% | 1,199,594 (New Position) | View |
| 2021-01-29 10:29 am Sale | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | ROYCE & ASSOCIATES LP | 491,453 2.44% | -500,039 (-50.43%) | View |
| 2020-03-20 09:42 am Purchase | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | LYTTON LAURENCE W | 1,010,718 5.7% | 1,010,718 (New Position) | View |
| 2020-02-14 12:18 pm Purchase | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | Nantahala Capital Management LLC | 1,239,983 7.1% | 1,239,983 (New Position) | View |
| 2020-01-21 2:45 pm Purchase | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | ROYCE & ASSOCIATES LP | 991,492 5.6% | 991,492 (New Position) | View |
| 2019-07-18 2:05 pm Purchase | 13D | CHEMBIO DIAGNOSTICS, INC. CEMI | PESSIN NORMAN H | 1,367,587 8% | 1,367,587 (New Position) | View |